Delta-Fly Pharmaの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/19 | 1,499 | 1,572 | 1,458 | 1,458 | -41 | -2.7% | 94,100 |
2021/08/18 | 1,436 | 1,508 | 1,430 | 1,499 | +49 | +3.4% | 64,000 |
2021/08/17 | 1,449 | 1,504 | 1,430 | 1,450 | +8 | +0.6% | 65,400 |
2021/08/16 | 1,482 | 1,485 | 1,424 | 1,442 | -61 | -4.1% | 90,300 |
2021/08/13 | 1,500 | 1,525 | 1,452 | 1,503 | -4 | -0.3% | 75,900 |
2021/08/12 | 1,540 | 1,549 | 1,492 | 1,507 | -54 | -3.5% | 68,900 |
2021/08/11 | 1,557 | 1,585 | 1,540 | 1,561 | +5 | +0.3% | 32,500 |
2021/08/10 | 1,496 | 1,568 | 1,493 | 1,556 | +20 | +1.3% | 62,800 |
2021/08/06 | 1,543 | 1,560 | 1,506 | 1,536 | +17 | +1.1% | 66,300 |
2021/08/05 | 1,527 | 1,587 | 1,515 | 1,519 | -8 | -0.5% | 95,600 |
2021/08/04 | 1,599 | 1,600 | 1,512 | 1,527 | -81 | -5% | 174,100 |
2021/08/03 | 1,649 | 1,673 | 1,595 | 1,608 | -24 | -1.5% | 58,200 |
2021/08/02 | 1,655 | 1,655 | 1,547 | 1,632 | -51 | -3% | 149,500 |
2021/07/30 | 1,714 | 1,715 | 1,624 | 1,683 | -31 | -1.8% | 119,000 |
2021/07/29 | 1,694 | 1,746 | 1,678 | 1,714 | +26 | +1.5% | 90,800 |
2021/07/28 | 1,744 | 1,757 | 1,662 | 1,688 | -95 | -5.3% | 175,100 |
2021/07/27 | 1,847 | 1,859 | 1,781 | 1,783 | -81 | -4.3% | 118,300 |
2021/07/26 | 1,921 | 1,928 | 1,842 | 1,864 | -22 | -1.2% | 104,000 |
2021/07/21 | 1,821 | 1,911 | 1,789 | 1,886 | +79 | +4.4% | 170,300 |
2021/07/20 | 1,811 | 1,885 | 1,795 | 1,807 | -22 | -1.2% | 142,300 |
2021/07/19 | 1,790 | 1,903 | 1,774 | 1,829 | +67 | +3.8% | 175,100 |
2021/07/16 | 1,719 | 1,789 | 1,691 | 1,762 | +45 | +2.6% | 125,100 |
2021/07/15 | 1,735 | 1,736 | 1,690 | 1,717 | -15 | -0.9% | 78,200 |
2021/07/14 | 1,717 | 1,749 | 1,705 | 1,732 | +35 | +2.1% | 59,200 |
2021/07/13 | 1,695 | 1,739 | 1,680 | 1,697 | +2 | +0.1% | 79,500 |
2021/07/12 | 1,698 | 1,725 | 1,655 | 1,695 | +18 | +1.1% | 113,300 |
2021/07/09 | 1,570 | 1,682 | 1,564 | 1,677 | +98 | +6.2% | 172,700 |
2021/07/08 | 1,605 | 1,631 | 1,550 | 1,579 | -46 | -2.8% | 210,700 |
2021/07/07 | 1,578 | 1,659 | 1,575 | 1,625 | +15 | +0.9% | 159,400 |
2021/07/06 | 1,620 | 1,644 | 1,558 | 1,610 | +5 | +0.3% | 327,500 |
2021/07/05 | 1,747 | 1,750 | 1,593 | 1,605 | -110 | -6.4% | 497,400 |
2021/07/02 | 1,946 | 1,977 | 1,677 | 1,715 | -271 | -13.6% | 605,600 |
2021/07/01 | 2,027 | 2,085 | 1,955 | 1,986 | -43 | -2.1% | 179,000 |
2021/06/30 | 2,025 | 2,075 | 1,965 | 2,029 | +2 | +0.1% | 155,900 |
2021/06/29 | 1,977 | 2,035 | 1,933 | 2,027 | +50 | +2.5% | 125,900 |
2021/06/28 | 1,946 | 2,013 | 1,923 | 1,977 | +28 | +1.4% | 129,100 |
2021/06/25 | 1,850 | 1,963 | 1,848 | 1,949 | +87 | +4.7% | 144,600 |
2021/06/24 | 1,867 | 1,980 | 1,848 | 1,862 | -5 | -0.3% | 235,000 |
2021/06/23 | 1,893 | 1,910 | 1,820 | 1,867 | +12 | +0.6% | 122,800 |
2021/06/22 | 1,793 | 1,857 | 1,769 | 1,855 | +121 | +7% | 129,400 |
2021/06/21 | 1,670 | 1,769 | 1,650 | 1,734 | -2 | -0.1% | 150,200 |
2021/06/18 | 1,818 | 1,818 | 1,720 | 1,736 | -68 | -3.8% | 210,600 |
2021/06/17 | 1,815 | 1,911 | 1,790 | 1,804 | -50 | -2.7% | 286,100 |
2021/06/16 | 1,749 | 1,869 | 1,720 | 1,854 | +113 | +6.5% | 264,200 |
2021/06/15 | 1,770 | 1,775 | 1,732 | 1,741 | -33 | -1.9% | 89,600 |
2021/06/14 | 1,724 | 1,796 | 1,678 | 1,774 | +49 | +2.8% | 177,900 |
2021/06/11 | 1,731 | 1,741 | 1,671 | 1,725 | +25 | +1.5% | 98,500 |
2021/06/10 | 1,656 | 1,716 | 1,638 | 1,700 | +6 | +0.4% | 118,900 |
2021/06/09 | 1,672 | 1,766 | 1,672 | 1,694 | +5 | +0.3% | 184,000 |
2021/06/08 | 1,689 | 1,762 | 1,664 | 1,689 | +98 | +6.2% | 357,000 |
801~
850
件表示中 / 1492件
類似銘柄と比較する
現在ご覧いただいている「DELTA-P」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
DELTA-P | 51,900円 | - | - | 0.00% | - | 14.89倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
キッズバイオ | 12,100円 | - | - | 0.00% | - | 6.37倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞(SHED)用いた再生医療に力 |
ブライトパス | 5,600円 | - | - | 0.00% | - | 3.94倍 |
|
久留米大学発創薬ベンチャー。がん向け遺伝子導入iPS由来細胞医薬や抗体医薬開発に注力 |
免疫生物 | 50,000円 | +13.4% | -4.0% | 0.00% | 40.49倍 | 3.49倍 |
|
研究用試薬の製販・受託。遺伝子組み換えカイコの基礎研究は休止し、化粧品等応用開発に移行 |
ファンペップ | 14,000円 | - | - | 0.00% | - | 2.12倍 |
|
大阪大医研発。患者の体内で抗体の産生を誘導する抗体誘導ペプチドを用いた医薬品を開発 |
市場注目の銘柄
チャート関連のコラム